Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Defining the role of BRCA2-deficient mammary stromal fibroblasts in the growth and transformation of mammary epithelial cells.
FY 2019-20
Summary
"Individuals who carry mutations in the DNA repair gene known as BRCA2, have a higher lifetime risk of developing breast cancer compared to those who do not carry the mutated version of the gene. In order to develop successful strategies for risk assessment and chemoprevention, it is vital to understand the events that lead to the progression of tumours in these patients. The transformation of mammary epithelial cells can be caused by the secretion of inflammatory cytokines. The release of these cytokines is induced by continuous exposure to DNA damage, and the resulting constitutively active DNA damage response. Research has shown that mammary glands that are BRCA2-deficient cause activation of the NF-κB pathway. This pathway mediates the production of interuleukin-6, which has a potent transforming activity on mammary epithelial cells. It is hypothesized that DNA damage in BRCA2mut/+ stromal fibroblasts results in the secretion of factors that contribute in a paracrine manner to the expansion of genomically unstable BRCA2mut/+ mammary luminal progenitors. "
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
429059
Name
Whitney Rachael
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Defining the role of BRCA2-deficient mammary stromal fibroblasts in the growth and transformation of mammary epithelial cells.
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brca2; Breast Cancer; Dna Damage; Genetics
Abstract
"Individuals who carry mutations in the DNA repair gene known as BRCA2, have a higher lifetime risk of developing breast cancer compared to those who do not carry the mutated version of the gene. In order to develop successful strategies for risk assessment and chemoprevention, it is vital to understand the events that lead to the progression of tumours in these patients. The transformation of mammary epithelial cells can be caused by the secretion of inflammatory cytokines. The release of these cytokines is induced by continuous exposure to DNA damage, and the resulting constitutively active DNA damage response. Research has shown that mammary glands that are BRCA2-deficient cause activation of the NF-κB pathway. This pathway mediates the production of interuleukin-6, which has a potent transforming activity on mammary epithelial cells. It is hypothesized that DNA damage in BRCA2mut/+ stromal fibroblasts results in the secretion of factors that contribute in a paracrine manner to the expansion of genomically unstable BRCA2mut/+ mammary luminal progenitors. "
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Whitney, Rachael
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~